Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionSilvant Capital Management LLC
Latest Disclosed Ownership1,411 shares
Latest Disclosed Value $ 196,651
Silvant Capital Management LLC ownership in GILD / Gilead Sciences, Inc.

On May 14, 2026 - Silvant Capital Management LLC filed a 13F-HR form disclosing ownership of 1,411 shares of Gilead Sciences, Inc. (US:GILD) valued at $196,651 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,411 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $182,005 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 197 13.29 0.0039
2026-02-13 2025-12-31 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 173 10.90 0.0058
2025-11-18 2025-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 1,411 0 0.00 157 0.00 0.0054
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 1,411 0 157 0.0031
2025-08-13 2025-06-30 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 156 -1.27 0.0059
2025-05-14 2025-03-31 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 158 21.54 0.0073
2025-02-13 2024-12-31 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 130 10.17 0.0054
2024-10-29 2024-09-30 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 118 22.92 0.0052
2024-07-25 2024-06-30 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 97 -6.80 0.0043
2024-04-30 2024-03-31 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 103 -9.65 0.0049
2024-01-25 2023-12-31 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 114 8.57 0.0061
2023-10-24 2023-09-30 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 106 -2.78 0.0064
2023-07-25 2023-06-30 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 109 -7.69 0.0061
2023-04-26 2023-03-31 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 117 -3.31 0.0076
2023-01-23 2022-12-31 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 121 39.08 0.0086
2022-11-09 2022-09-30 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 87 0.00 0.0059
2022-08-03 2022-06-30 13F GILEAD SCIENCES COM 375558103 1,411 0 0.00 87 3.57 0.0211
2022-05-05 2022-03-31 13F GILEAD SCIENCES COM 375558103 1,411 -24,463 -94.55 84 -95.53 0.0160
2022-02-07 2021-12-31 13F GILEAD SCIENCES COM 375558103 25,874 -1,460 -5.34 1,879 -1.57 0.3211
2021-11-08 2021-09-30 13F GILEAD SCIENCES COM 375558103 27,334 -2,472 -8.29 1,909 -7.01 0.3409
2021-08-03 2021-06-30 13F GILEAD SCIENCES COM 375558103 29,806 -672 -2.20 2,053 4.21 0.3235
2021-05-11 2021-03-31 13F GILEAD SCIENCES COM 375558103 30,478 0 0.00 1,970 10.92 0.3365
2021-02-05 2020-12-31 13F GILEAD SCIENCES COM 375558103 30,478 -148 -0.48 1,776 -8.22 0.3034
2020-11-09 2020-09-30 13F GILEAD SCIENCES COM 375558103 30,626 -536 -1.72 1,935 -19.31 0.3621
2020-08-11 2020-06-30 13F GILEAD SCIENCES COM 375558103 31,162 0 0.00 2,398 2.96 0.4311
2020-05-13 2020-03-31 13F GILEAD SCIENCES COM 375558103 31,162 0 0.00 2,329 15.01 0.5075
2020-02-10 2019-12-31 13F GILEAD SCIENCES COM 375558103 31,162 -168 -0.54 2,025 1.96 0.3693
2019-11-12 2019-09-30 13F GILEAD SCIENCES COM 375558103 31,330 -289 -0.91 1,986 -7.02 0.3925
2019-08-09 2019-06-30 13F GILEAD SCIENCES COM 375558103 31,619 -258 -0.81 2,136 3.09 0.3826
2019-05-10 2019-03-31 13F GILEAD SCIENCES COM 375558103 31,877 -180 -0.56 2,072 3.29 0.3722
2019-02-06 2018-12-31 13F GILEAD SCIENCES COM 375558103 32,057 -36,438 -53.20 2,006 -62.07 0.4010
2018-11-07 2018-09-30 13F GILEAD SCIENCES COM 375558103 68,495 -466 -0.68 5,289 8.27 0.6524
2018-08-13 2018-06-30 13F GILEAD SCIENCES COM 375558103 68,961 861 1.26 4,885 -4.85 0.6036
2018-05-09 2018-03-31 13F GILEAD SCIENCES COM 375558103 68,100 68,100 5,134 0.6590
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.